Advanced clinical trials are underway for at least 10 promising therapies for Alzheimer's disease. According to a new report from the RAND Corporation, the U.S. health care system lacks the capacity to move a treatment rapidly from approval into wide clinical use. Millions of patients could miss out on transformative care if such a breakthrough occurs. In the U.S., an estimated 5.5 million patients live with Alzheimer's-related dementia today, a number that is projected to increase to 11.6 million by 2040.
The report can be obtained at https://www.rand.org/pubs/research_reports/RR2272.html.